Lupin Strengthens Diabetes Portfolio with Acquisition of Three Anti-Diabetes Trademarks from Boehringer Ingelheim Elets Source link
Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim International CNBCTV18 Source link
Boehringer Cashes In Co-Marketed Diabetes Brands Ahead Of India Empagliflozin Expiry Scrip Source link
Torrent Pharma to acquire three anti-diabetes brands from Boehringer Ingelheim Business Standard Source link
Torrent Pharma to acquire 3 anti-diabetes brands from Boehringer Ingelheim CNBCTV18 Source link